In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $4.96 in the prior trading day, Medical Properties Trust Inc (NYSE: MPW) closed at $4.86, down -2.02%. In other words, the price has decreased by -$2.02 from its previous closing price. On the day, 8.91 million shares were traded. MPW stock price reached its highest trading level at $4.985 during the session, while it also had its lowest trading level at $4.8.
Ratios:
Our goal is to gain a better understanding of MPW by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.54. For the most recent quarter (mrq), Quick Ratio is recorded 2.76 and its Current Ratio is at 2.76. In the meantime, Its Debt-to-Equity ratio is 2.00 whereas as Long-Term Debt/Eq ratio is at 2.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, Exane BNP Paribas on March 12, 2025, Upgraded its rating to Outperform and sets its target price to $9 from $5 previously.
On September 13, 2024, Colliers Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $6.50.
Exane BNP Paribas Downgraded its Outperform to Neutral on July 02, 2024, while the target price for the stock was maintained at $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 05 ’25 when Stewart Michael G sold 29,000 shares for $5.20 per share. The transaction valued at 150,800 led to the insider holds 216,100 shares of the business.
Stewart Michael G bought 29,000 shares of MPW for $150,800 on May 05 ’25. On Mar 05 ’25, another insider, Hanna James Kevin, who serves as the Senior VP, Controller & CAO of the company, bought 7,411 shares for $5.75 each. As a result, the insider paid 42,613 and bolstered with 372,338 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MPW now has a Market Capitalization of 2921346304 and an Enterprise Value of 12061606912. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.17 while its Price-to-Book (P/B) ratio in mrq is 0.60. Its current Enterprise Value per Revenue stands at 12.249 whereas that against EBITDA is 18.442.
Stock Price History:
The Beta on a monthly basis for MPW is 1.45, which has changed by 0.04967606 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, MPW has reached a high of $6.34, while it has fallen to a 52-week low of $3.51. The 50-Day Moving Average of the stock is -0.99%, while the 200-Day Moving Average is calculated to be -0.17%.
Shares Statistics:
The stock has traded on average 8.42M shares per day over the past 3-months and 5980220 shares per day over the last 10 days, according to various share statistics. A total of 600.81M shares are outstanding, with a floating share count of 495.60M. Insiders hold about 17.55% of the company’s shares, while institutions hold 58.17% stake in the company. Shares short for MPW as of 1760486400 were 155978804 with a Short Ratio of 18.52, compared to 1757894400 on 165026257. Therefore, it implies a Short% of Shares Outstanding of 155978804 and a Short% of Float of 37.26.
Dividends & Splits
In the trailing 12 months, MPW’s forward annual dividend rate was 0.32, compared to 0.32 this year. Against a Trailing Annual Dividend Yield of 0.06451613. The stock’s 5-year Average Dividend Yield is 9.97.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of Medical Properties Trust Inc (MPW).The consensus estimate for the next quarter is $0.03, with high estimates of $0.06 and low estimates of $0.01.
Analysts are recommending an EPS of between $0.24 and -$0.35 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is $0.12, with 1 analysts recommending between $0.12 and $0.12.
Revenue Estimates
5 analysts predict $245.79M in revenue for. The current quarter. It ranges from a high estimate of $272.36M to a low estimate of $233M. As of. The current estimate, Medical Properties Trust Inc’s year-ago sales were $225.83MFor the next quarter, 5 analysts are estimating revenue of $247.64M. There is a high estimate of $273.66M for the next quarter, whereas the lowest estimate is $236.85M.
A total of 6 analysts have provided revenue estimates for MPW’s current fiscal year. The highest revenue estimate was $1.09B, while the lowest revenue estimate was $932.6M, resulting in an average revenue estimate of $970.69M. In the same quarter a year ago, actual revenue was $995.55MBased on 6 analysts’ estimates, the company’s revenue will be $1.04B in the next fiscal year. The high estimate is $1.1B and the low estimate is $981.14M.
